Citation:Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, et al 2015
From Cancer Guidelines Wiki
Citation
Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, et al. Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis. Onco Targets Ther 2015;8:3349-59 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26622183.
Critical appraisals
| Critical appraisal link | Clinical question | Assigned to | Status |
|---|---|---|---|
| Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, et al 2015 | Ovarian suppression during chemotherapy | Dr Wanyuan Cui MBBS BMEDSCI FRACP | completed |
Compare quality appraisals for each clinical question
- [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»]] (compare critical appraisals)